Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver.

Bill, RubenRubenBillMontani, MatteoMatteoMontani0000-0001-5377-0875Blum, BenediktBenediktBlumDufour, Jean-FrançoisJean-FrançoisDufourEscher, RobertRobertEscherBühlmann, MichaelMichaelBühlmann2024-10-072024-10-072018-07https://boris-portal.unibe.ch/handle/20.500.12422/59878en600 - Technology::610 - Medicine & health500 - Science::570 - Life sciences; biology600 - TechnologyFavorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver.article10.7892/boris.1201772947397210.1002/hep.29853